Allyl bromide → HCID 11626839, compound
Reaction equation
[CH:1]12[NH:8][CH:5]([CH2:6][CH2:7]1)[CH2:4][CH:3]([CH:9]1[C:22]3[CH:21]=[CH:20][C:19]([C:23]4[CH:28]=[CH:27][CH:26]=[CH:25][C:24]=4[NH:29][C:30](=[O:32])[CH3:31])=[CH:18][C:17]=3[O:16][C:15]3[C:10]1=[CH:11][CH:12]=[CH:13][CH:14]=3)[CH2:2]2.C(=O)([O-])[O-].[K+].[K+].[CH2:39](Br)[CH:40]=[CH2:41]>CN(C=O)C>[CH2:41]([N:8]1[CH:1]2[CH2:7][CH2:6][CH:5]1[CH2:4][CH:3]([CH:9]1[C:22]3[CH:21]=[CH:20][C:19]([C:23]4[CH:28]=[CH:27][CH:26]=[CH:25][C:24]=4[NH:29][C:30](=[O:32])[CH3:31])=[CH:18][C:17]=3[O:16][C:15]3[C:10]1=[CH:11][CH:12]=[CH:13][CH:14]=3)[CH2:2]2)[CH:40]=[CH2:39]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of N-{2-[9-(8-Aza-bicyclo[3.2.1]oct-3-yl)-9H-xanthen-3-yl]-phenyl}-acetamide, 7b (53 mg, 0.125 mmol) in DMF (0.5 mL) at 0° C. were added potassium carbonate (18 mg, 0.13 mmol) and allyl bromide (10.6 μL, 0.122 mmol). The mixture was stirred overnight at rt, and poured onto H2O. The solid was separated via filtration and washed with H2O. The solid was purified via reverse phase HPLC (eleuent gradient: 10% to 90% CH3CN in H2O containing 0.1% TFA) to yield 25 mg (36%) of N-{2-[9-(8-allyl-8-aza-bicyclo[3.2.1]oct-3-yl)-9H-xanthen-3-yl]-phenyl}-acetamide, 18b. MS 18b: m/z: 464.9 (MH+).
Workup
- additionpoured onto H2O
- customThe solid was separated via filtration
- washwashed with H2O
- customThe solid was purified via reverse phase HPLC (eleuent gradient: 10% to 90% CH3CN in H2O containing 0.1% TFA)
Sources & evidence
- ORD record
- ord-e0a912064cd74d839e33a00b767549d1
- Source dataset
- uspto-grants-2009_09
- Patent number
- US07589104B2
Reaction notes
Loading…